epigallocatechin gallate
AssetAlso Previfenon®, PF-EGCG 90, NVP-XAA 723, TEAVIGO
Green tea polyphenol with antioxidant, anti-inflammatory, and antiviral properties
- Stage
- Phase 2
- Modality
- Supplement
- Target
- Oxidative stress and ROS signalling
- 2
- Indications
- 20
- Trials
- 1
- Developer
Indications
2COVID-19
Phase 2, Unknown, NCT04446065, clinicaltrials.gov, 7 Oct 2026
Sars cov2
Phase 2, Unknown, NCT04446065, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials20
- Evidence for its targets3
- Competitors5
- Aging relevance1
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.